Bythos-Biotechnologies for Human Health and Blue Growth
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (20 June 2020) | Viewed by 305
Special Issue Editor
Interests: defense mechanisms in invertebrates and fish (cytotoxicity, opsonization, phagocytosis, agglutination, antimicrobial and antitumoral peptides); bioactive molecules extraction; circular economy and sustainability: natural marine extract from fish waste to packaging and nutraceutical use
Special Issue Information
Bythos—Biotechnologies for Human Health and Blue Growth—is an Interreg V-I Italia–Malta project which focuses on the transformation of waste from the fisheries sector into products of use for human health.
Dear Colleagues,
The marine environment is an extremely precious source of products; however, the extraction of these products and their potential use in the industry is not always environmentally or financially sustainable. The fisheries sector, which includes fish processing factories, factory ships, and artisan fishing, could provide a considerable source of fish waste to local economies. In the Mediterranean, oily fish and tuna, which are the main species of interest to the industry, are also extremely rich in active compounds. Today, between 50% and 70% of fish matter is not considered of value for human consumption; the skins, skeleton, viscera, and scales are treated as special waste and incinerated or disposed of directly at sea, with loss of a bevy of valuable products which could help bring sustainability to an ailing fisheries sector. This Special Issue will focus on marine-derived ingredients from fish waste which have a strong circular economy nature and are of particular interest as pharmaceuticals, cosmeceuticals, nutraceuticals, functional foods, and nutritional supplements for humans and animal husbandry.
Topics of interest of this Special Issue include the following:
- Marine collagen (quality, simplified extraction procedures, etc.)
- Bioactive molecule-based antibacterial/antimicrobial/antitumor products
- Innovative applications of BAMs for human health (packaging, shelf-life prolongation)
- Biomaterials of marine origin
- Marine-derived functional foods and nutritional supplements
- Marine natural products with activity against human, animal, and plant diseases
We expect this Special Issue to provide new and exciting procedures and new products derived from fish waste that will contribute to the Blue Economy and its inherent circularity, to human health (also through improved fish health), and to the sustainability of our oceans. We hope to change the way fish waste is considered, bringing to the forefront its true value as a potentially zero-waste resource for the future.
Considering you as a potential author, we are pleased to invite you to submit an original scientific contribution or review for this Special Issue “Biotechnologies for Human Health and Blue Growth” which will appear in Marine Drugs.
We look forward to publishing your work in this Special Issue, together with many interesting papers from other research groups in the field.
Prof. Dr. Mirella VazzanaGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bioactive molecules
- Marine natural extracts
- Natural antimicrobial peptides
- Natural anticancer molecules
- Marine nutraceutical products
- Marine-derived functional foods and nutritional supplements
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
